Australian biotech market today 06.05.09
Wednesday, 06 May, 2009
A very flat day’s trading today at 1.30pm, with the healthcare index down slightly along with the rest of the All Ordinaries.
The biotech majors (COH, CSL, RMD) regained some lost ground from yesterday, while Pharmaxis (ASX:PXS) is down a little after yesterday’s gains.
Novogen (ASX:NRT) is up a cent to 46c.
Singapore company SciGen (ASX:SIE) has told the ASX it is unaware of any reason why its stocks are experiencing turbulence at the moment – high volumes have been traded although the share price remains a tiny 12c.
The company appointed a new CEO and chairman a fortnight ago, with founder Saul Mashaal standing down.
Heart muscle regeneration genes mapped
Researchers have uncovered insights into how stem cells develop and mature into heart muscle...
The cause of 2022's mpox outbreak revealed
Researchers have discovered that the strain of mpox behind the 2022 outbreak was a weakened form...
New gene therapy treats liver disorder in growing children
Researchers have developed a genome-editing approach that repairs a faulty gene directly at its...
